Articles from Mira Pharmaceuticals, Inc.

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
Completion of 7-Day Toxicology and Pharmacokinetic Studies Advances Non-Opioid Pain Therapy and Obesity Candidate Development
By Mira Pharmaceuticals, Inc. · Via GlobeNewswire · July 30, 2026
Articles from Mira Pharmaceuticals, Inc. | MarketMinute